Overall survival (OS) with encorafenib (enco) + cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Desai, J.; Kopetz, S.; Aderka, D.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Singh Wasan, H.; Yoshino, T.; Ciardiello, F.; Chantrill, L.; Tebbutt, N.; Strickland, A.; Price, T.; Karapetis, C.; Murphy, F.; Gollerkeri, A.; Golden, A.; Edwards, M. L.; Tabernero, J. |
| Abstract Title: | Overall survival (OS) with encorafenib (enco) + cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC) |
| Meeting Title: | 48th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 17 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2021 Nov 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-11-01 |
| Start Page: | 119 |
| End Page: | 120 |
| Language: | English |
| ACCESSION: | WOS:000717281500166 |
| PROVIDER: | wos |
| PUBMED: | 34766444 |
| DOI: | 10.1111/ajco.13716 |
| Notes: | Meeting Abstract: 221 -- Source: Wos |
